Aishwaray Enterprises Franchise
About Us:
Sanjog stands at the forefront of the rapidly expanding retail pharmacy landscape, making waves across India with its dynamic presence. Our extensive product portfolio spans the entire spectrum of healthcare, encompassing Anticancer medications, Allopathic treatments, Local medicines, Surgical supplies, AYURVEDA remedies, Homeopathic solutions, Generic medicines, General pharmaceuticals, Over-the-Counter essentials, Cosmetics, Baby care products, and much more.
At Sanjog, we are committed to meeting the diverse needs of our customers, tailoring our offerings to match their prescriptions and preferences. Unlike other establishments, we don’t push products indiscriminately. Instead, we operate as a comprehensive pharmacy franchise that adapts to the unique demands of each area and the preferences of our valued clientele, even providing the convenience of round-the-clock service.
Our pharmacy proudly enjoys the support of the esteemed Dabur India brand. This partnership allows us to extend the entire range of Dabur India products to our customers, complete with distributorship margins, should the demand arise.
Beyond pharmaceuticals, we also extend our services to diagnostic centers. Depending on the requirements and preferences, we collaborate with renowned names such as Metropolis, Pathkind, SRL lab, and Lalpath lab.
To further enhance the customer experience, we offer online order services and dedicated support.
Franchise Details:
- Minimum Area Requirement: 150 to 200 sq. ft. (Maximum area varies based on investor budgets)
- Investment Range: Approximately 10 to 12 lac or as per area square footage
- Franchise Fee: 3 lac plus GST
- ROI Period: Typically within 1.5 years, subject to shop location
- Agreement Period: 5 years
Join the Sanjog family and embark on a rewarding journey in the thriving pharmaceutical and healthcare industry. Together, we can build a healthier, happier tomorrow.
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.
